Global Biosimilar Drug Market Size and Forecast to 2021


Report ID : RNR-191039 Category : Medical Devices Published Date : 7-Sep-2017
Publisher : 9Dimen Pages : 81 Format : PDF
Biosimilar Drug Report by Material, Application, and Geography ? Global Forecast to 2021 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom,Japan, South Korea and China).

In this report, the global Biosimilar Drug market is valued at USD XX million in 2017 and is projected to reach USD XX million by the end of 2021, growing at a CAGR of XX% during the period 2017 to 2021.

The report firstly introduced the Biosimilar Drug basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include:
Hengrui Medicine
Hisun Pharm
MSD
Pfizer
Novartis
Boehringer
??

The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
mAbs (Monoclonal Antibodies)
FC-Fusion Proteins
EPO (Erythropoietin)
??

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Biosimilar Drug for each application, including-
Oncology
Diabetes
Rheumatoid arthritis
Table of Contents 

Part I Biosimilar Drug Industry Overview 

Chapter One Biosimilar Drug Industry Overview 
1.1 Biosimilar Drug Definition 
1.2 Biosimilar Drug Classification and Product Type Analysis 
mAbs (Monoclonal Antibodies) 
FC-Fusion Proteins 
EPO (Erythropoietin) 
?? 
1.3 Biosimilar Drug Application and Down Stream Market Analysis 
Oncology 
Diabetes 
Rheumatoid arthritis 
?? 
1.4 Biosimilar Drug Industry Chain Structure Analysis 
1.5 Biosimilar Drug Industry Development Overview 
1.6 Biosimilar Drug Global Market Comparison Analysis 
1.6.1 Biosimilar Drug Global Import Market Analysis 
1.6.2 Biosimilar Drug Global Export Market Analysis 
1.6.3 Biosimilar Drug Global Main Region Market Analysis 
1.6.4 Biosimilar Drug Global Market Comparison Analysis 
1.6.5 Biosimilar Drug Global Market Development Trend Analysis 

Part II Asia Biosimilar Drug Industry (The Report Company Including the Below Listed But Not All) 

Chapter Two 2012-2017 Asia Biosimilar Drug Productions Supply Sales Demand Market Status and Forecast 
2.1 2012-2017 Biosimilar Drug Capacity Production Overview 
2.2 2012-2017 Biosimilar Drug Production Market Share Analysis 
2.3 2012-2017 Biosimilar Drug Demand Overview 
2.4 2012-2017 Biosimilar Drug Supply Demand and Shortage Analysis 
2.5 2012-2017 Biosimilar Drug Import Export Consumption Analysis 
2.6 2012-2017 Biosimilar Drug Cost Price Production Value Profit Analysis 

Chapter Three Asia Biosimilar Drug Key Manufacturers Analysis 
3.1 Hengrui Medicine 
3.1.1 Product Picture and Specification 
3.1.2 Capacity Production Price Cost Production Value Analysis 
3.1.3 Contact Information 

3.2 Hisun Pharm 
3.2.1 Product Picture and Specification 
3.2.2 Capacity Production Price Cost Production Value Analysis 
3.2.3 Contact Information 

3.3 Company C 
3.3.1 Product Picture and Specification 
3.3.2 Capacity Production Price Cost Production Value Analysis 
3.3.3 Contact Information 
... 
... 
Chapter Four Asia Biosimilar Drug Industry Development Trend 
4.1 2017-2021 Biosimilar Drug Capacity Production Trend 
4.2 2017-2021 Biosimilar Drug Production Market Share Analysis 
4.3 2017-2021 Biosimilar Drug Demand Trend 
4.4 2017-2021 Biosimilar Drug Supply Demand and Shortage Analysis 
4.5 2017-2021 Biosimilar Drug Import Export Consumption Analysis 
4.6 2017-2021 Biosimilar Drug Cost Price Production Value Profit Analysis 

Part III North American Biosimilar Drug Industry (The Report Company Including the Below Listed But Not All) 

Chapter Five 2012-2017 North American Biosimilar Drug Productions Supply Sales Demand Market Status and Forecast 
5.1 2012-2017 Biosimilar Drug Capacity Production Overview 
5.2 2012-2017 Biosimilar Drug Production Market Share Analysis 
5.3 2012-2017 Biosimilar Drug Demand Overview 
5.4 2012-2017 Biosimilar Drug Supply Demand and Shortage Analysis 
5.5 2012-2017 Biosimilar Drug Import Export Consumption Analysis 
5.6 2012-2017 Biosimilar Drug Cost Price Production Value Profit Analysis 

Chapter Six North American Biosimilar Drug Key Manufacturers Analysis 
6.1 MSD 
6.1.1 Product Picture and Specification 
6.1.2 Capacity Production Price Cost Production Value Analysis 
6.1.3 Contact Information 

6.2 Pfizer 
6.2.1 Product Picture and Specification 
6.2.2 Capacity Production Price Cost Production Value Analysis 
6.2.3 Contact Information 
... 
... 
Chapter Seven North American Biosimilar Drug Industry Development Trend 
7.1 2017-2021 Biosimilar Drug Capacity Production Trend 
7.2 2017-2021 Biosimilar Drug Production Market Share Analysis 
7.3 2017-2021 Biosimilar Drug Demand Trend 
7.4 2017-2021 Biosimilar Drug Supply Demand and Shortage Analysis 
7.5 2017-2021 Biosimilar Drug Import Export Consumption Analysis 
7.6 2017-2021 Biosimilar Drug Cost Price Production Value Profit Analysis 

Part IV Europe Biosimilar Drug Industry Analysis (The Report Company Including the Below Listed But Not All) 

Chapter Eight 2012-2017 Europe Biosimilar Drug Productions Supply Sales Demand Market Status and Forecast 
8.1 2012-2017 Biosimilar Drug Capacity Production Overview 
8.2 2012-2017 Biosimilar Drug Production Market Share Analysis 
8.3 2012-2017 Biosimilar Drug Demand Overview 
8.4 2012-2017 Biosimilar Drug Supply Demand and Shortage Analysis 
8.5 2012-2017 Biosimilar Drug Import Export Consumption Analysis 
8.6 2012-2017 Biosimilar Drug Cost Price Production Value Profit Analysis 

Chapter Nine Europe Biosimilar Drug Key Manufacturers Analysis 
9.1 Novartis 
9.1.1 Product Picture and Specification 
9.1.2 Capacity Production Price Cost Production Value Analysis 
9.1.3 Contact Information 

9.2 Boehringer 
9.2.1 Product Picture and Specification 
9.2.2 Capacity Production Price Cost Production Value Analysis 
9.2.3 Contact Information 
... 
... 
Chapter Ten Europe Biosimilar Drug Industry Development Trend 
10.1 2017-2021 Biosimilar Drug Capacity Production Trend 
10.2 2017-2021 Biosimilar Drug Production Market Share Analysis 
10.3 2017-2021 Biosimilar Drug Demand Trend 
10.4 2017-2021 Biosimilar Drug Supply Demand and Shortage Analysis 
10.5 2017-2021 Biosimilar Drug Import Export Consumption Analysis 
10.6 2017-2021 Biosimilar Drug Cost Price Production Value Profit Analysis 

Part V Biosimilar Drug Marketing Channels and Investment Feasibility 

Chapter Eleven Biosimilar Drug Marketing Channels Development Proposals Analysis 
11.1 Biosimilar Drug Marketing Channels Status 
11.2 Biosimilar Drug Marketing Channels Characteristic 
11.3 Biosimilar Drug Marketing Channels Development Trend 
11.2 New Firms Enter Market Strategy 
11.3 New Project Investment Proposals 

Chapter Twelve Development Environmental Analysis 
12.1 China Macroeconomic Environment Analysis 
12.2 European Economic Environmental Analysis 
12.3 United States Economic Environmental Analysis 
12.4 Japan Economic Environmental Analysis 
12.5 Global Economic Environmental Analysis 

Chapter Thirteen Biosimilar Drug New Project Investment Feasibility Analysis 
13.1 Biosimilar Drug Market Analysis 
13.2 Biosimilar Drug Project SWOT Analysis 
13.3 Biosimilar Drug New Project Investment Feasibility Analysis 

Part VI Global Biosimilar Drug Industry Conclusions 

Chapter Fourteen 2012-2017 Global Biosimilar Drug Productions Supply Sales Demand Market Status and Forecast 
14.1 2012-2017 Biosimilar Drug Capacity Production Overview 
14.2 2012-2017 Biosimilar Drug Production Market Share Analysis 
14.3 2012-2017 Biosimilar Drug Demand Overview 
14.4 2012-2017 Biosimilar Drug Supply Demand and Shortage Analysis 
14.5 2012-2017 Biosimilar Drug Cost Price Production Value Profit Analysis 

Chapter Fifteen Global Biosimilar Drug Industry Development Trend 
15.1 2017-2021 Biosimilar Drug Capacity Production Trend 
15.2 2017-2021 Biosimilar Drug Production Market Share Analysis 
15.3 2017-2021 Biosimilar Drug Demand Trend 
15.4 2017-2021 Biosimilar Drug Supply Demand and Shortage Analysis 
15.5 2017-2021 Biosimilar Drug Cost Price Production Value Profit Analysis 

Chapter Sixteen Global Biosimilar Drug Industry Research Conclusions